Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 1

NCT03114319

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

The purpose of this first in human (FIH) trial was to characterize the safety and tolerability of the SHP2 inhibitor TNO155 alone and in combination with EGF816…

United States, Canada227 participantsStarted 2017-05-26

Treatment: TNO155, TNO155 in combination with EGF816 (nazartinib)